p27 transcriptionally coregulates cJun to drive programs of tumor progression

H Yoon, M Kim, K Jang, M Shin… - Proceedings of the …, 2019 - National Acad Sciences
H Yoon, M Kim, K Jang, M Shin, A Besser, X Xiao, D Zhao, SA Wander, K Briegel, L Morey
Proceedings of the National Academy of Sciences, 2019National Acad Sciences
p27 shifts from CDK inhibitor to oncogene when phosphorylated by PI3K effector kinases.
Here, we show that p27 is a cJun coregulator, whose assembly and chromatin association is
governed by p27 phosphorylation. In breast and bladder cancer cells with high
p27pT157pT198 or expressing a CDK-binding defective p27pT157pT198 phosphomimetic
(p27CK− DD), cJun is activated and interacts with p27, and p27/cJun complexes localize to
the nucleus. p27/cJun up-regulates TGFB2 to drive metastasis in vivo. Global analysis of …
p27 shifts from CDK inhibitor to oncogene when phosphorylated by PI3K effector kinases. Here, we show that p27 is a cJun coregulator, whose assembly and chromatin association is governed by p27 phosphorylation. In breast and bladder cancer cells with high p27pT157pT198 or expressing a CDK-binding defective p27pT157pT198 phosphomimetic (p27CK−DD), cJun is activated and interacts with p27, and p27/cJun complexes localize to the nucleus. p27/cJun up-regulates TGFB2 to drive metastasis in vivo. Global analysis of p27 and cJun chromatin binding and gene expression shows that cJun recruitment to many target genes is p27 dependent, increased by p27 phosphorylation, and activates programs of epithelial–mesenchymal transformation and metastasis. Finally, human breast cancers with high p27pT157 differentially express p27/cJun-regulated genes of prognostic relevance, supporting the biological significance of the work.
National Acad Sciences